Savara Reports Fourth Quarter And Full Year 2018 Financial Results And Provides Business Update
On-Track to Report Top Line Results from Pivotal Phase 3 IMPALA Study at End of Q2 2019 AUSTIN, TX /...
On-Track to Report Top Line Results from Pivotal Phase 3 IMPALA Study at End of Q2 2019 AUSTIN, TX /...
TORONTO, ON / ACCESSWIRE / March 13, 2019 / Easton Pharmaceuticals Inc. (OTC PINK: EAPH) Provides Update on Its $2,600,000...
86,000 square foot planned cultivation facility expected to produce 28000 pounds of flower annually LAS VEGAS, NV / ACCESSWIRE /...
OXFORD, UK / ACCESSWIRE / March 13, 2019 / IntraBio Inc., a late-stage biopharmaceutical company, today announced that the US...
Presentation with live audio webcast on Tuesday, March 19, 2019 at 3:20 p.m. ET NEW HOPE, PA / ACCESSWIRE /...
SOUTH SAN FRANCISCO, CA / ACCESSWIRE / March 13, 2019 / VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing...